Table 2.

Mean ± SE of data for RPW larvae that were treated with eugenol derivatives.

Treatment	Concentration (ppm)	Consumption (g/day)	RGR (g/g day)	RCR (g/g day)	ECI	FDI (%)
Control	0	0.386 ± 0.013 *	−0.011 ± 0.01	0.316 ± 0.039 a	−9.156 ±1.8 ab	-
WN11	200	0.215 ± 0.003 a,A	−0.008 ± 0.00	0.090 ± 0.005 b	−2.120 ± 4.38 ab	44.22 ab,A
	400	0.207 ± 0.002 b,A	−0.016 ± 0.01	0.095 ± 0.007 b	−22.78 ± 7.98 a	46.37 b,A
	600	0.228 ± 0.0004 a,B	−0.027 ± 0.02	0.159 ± 0.041 b	−14.93 ± 12.9 ab	40.73 a,A
WN14	200	0.240 ± 0.001 a,AB	−0.001 ± 0.01	0.1692 ± 0.024 b	2.899 ± 8.21 ab	37.74 a,A
	400	0.241 ± 0.002 d,B	−0.006 ± 0.02	0.214 ± 0.029 ab	0.733 ± 18.15 ab	37.43 a,A
	600	0.235 ± 0.0006 ab,A	0.019 ±0.01	0.212 ± 0.058 ab	19.15 ± 11.18 ab	39.13 a,A
WN15	200	0.237 ± 0.002 a,C	0.017 ± 0.001	0.096 ± 0.003 b	25.72 ± 1.51 b	38.47 ab,A
	400	0.218 ± 0.001 c,A	−0.023 ± 0.01	0.129 ± 0.014 b	−7.499 ± 7.25 ab	43.49 ab,A
	600	0.225 ± 0.0008 a,B	−0.007 ± 0.01	0.112 ± 0.013 b	2.10 ± 11.04 ab	41.71 a,A
WN16	200	0.210 ± 0.014 a,AB	−0.005 ± 0.01	0.099 ± 0.013 b	−3.127 ± 7.51 ab	45.74 b,B
	400	0.177 ± 0.004 a,A	−0.009 ± 0.02	0.093 ± 0.021 b	−8.855 ± 12.0 ab	54.14 c,C
	600	0.245 ± 0.006 b,B	−0.022 ± 0.00	0.143 ± 0.023 b	−15.16 ± 2.27 ab	36.59 a,A

The symbol * indicates that it is significantly higher when compared with all other treatments (p < 0.05). The same small letter indicates that there was no significant difference between the derivatives at the same concentration (p > 0.05). The same capital letter indicates that no significant difference existed between concentrations in each derivative (p > 0.05).